Generic vs. higher-priced name brand drugs : a medicaid cost impact study

LDR 00877cam a2200205 i 4500
001 100786780
003 MiAaHDL
005 20150806000000.0
006 m d
007 cr bn ---auaua
008 770310s1977 nyua s00010 eng d
035 ‡asdr-uiuc340935
035 ‡9ABJ-7715
035 ‡a(OCoLC)2791007
040 ‡aNYG ‡cNYG ‡dUIU
245 0 0 ‡aGeneric vs. higher-priced name brand drugs : ‡ba medicaid cost impact study / ‡c[prepared by David L. Rosen, et. al.]
260 0 ‡a[New York] : ‡bState of New York, Department of Audit and Control, Office of Welfare Inspector General, ‡c1977.
300 ‡a26, 4 leaves : ‡bill. ; ‡c28 cm.
538 ‡aMode of access: Internet.
650 0 ‡aDrugs ‡xPrices ‡zNew York (State) ‡zNew York.
650 0 ‡aMedicaid ‡zNew York (State) ‡zNew York ‡xCosts.
700 1 0 ‡aRosen, David L.
710 1 0 ‡aNew York (State). ‡bOffice of Welfare Inspector General
740 2 1 ‡aA medicaid cost impact study.
CID ‡a100786780
DAT 0 ‡a20020415161444.0 ‡b20150806000000.0
DAT 1 ‡a20180312222515.0 ‡b2024-03-18T17:53:35Z
DAT 2 ‡a2024-03-18T17:30:01Z ‡b2019-03-30T20:00:02Z
CAT ‡aSDR-UIUC ‡dUNKNOWN ‡lprepare.pl-004-007
FMT ‡aBK
HOL ‡0sdr-uiuc340935 ‡auiug ‡bSDR ‡cUIUC ‡puiug.30112088562001 ‡sUIU ‡1340935
974 ‡bUIU ‡cUIUC ‡d20240318 ‡sgoogle ‡uuiug.30112088562001 ‡y1977 ‡rpdus ‡qncn
974 ‡bUIU ‡cUIUC ‡d20240702 ‡sgoogle ‡uuiug.30112000995032 ‡y1977 ‡rpdus ‡qncn